Literature DB >> 26170383

Oil-in-Water Emulsion MF59 Increases Germinal Center B Cell Differentiation and Persistence in Response to Vaccination.

Giuseppe Lofano1, Francesca Mancini2, Giulia Salvatore2, Rocco Cantisani2, Elisabetta Monaci2, Corrado Carrisi2, Simona Tavarini2, Chiara Sammicheli2, Silvia Rossi Paccani2, Elisabetta Soldaini2, Donatello Laera2, Oretta Finco2, Sandra Nuti2, Rino Rappuoli2, Ennio De Gregorio2, Fabio Bagnoli2, Sylvie Bertholet3.   

Abstract

Induction of persistent protective immune responses is a key attribute of a successful vaccine formulation. MF59 adjuvant, an oil-in-water emulsion used in human vaccines, is known to induce persistent high-affinity functional Ab titers and memory B cells, but how it really shapes the Ag-specific B cell compartment is poorly documented. In this study, we characterized the Ab- and Ag-specific B cell compartment in wild-type mice immunized with HlaH35L, a Staphylococcus aureus Ag known to induce measurable functional Ab responses, formulated with MF59 or aluminum salts, focusing on germinal centers (GC) in secondary lymphoid organs. Taking advantage of single-cell flow cytometry analyses, HlaH35L-specific B cells were characterized for the expression of CD38 and GL-7, markers of memory and GC, respectively, and for CD80 and CD73 activation markers. We demonstrated that immunization with MF59-, but not aluminum salt-adjuvanted HlaH35L, induced expanded Ag-specific CD73(+)CD80(-) GC B cells in proximal- and distal-draining lymph nodes, and promoted the persistence of GC B cells, detected up to 4 mo after immunization. In addition to increasing GC B cells, MF59-adjuvanted HlaH35L also increased the frequency of T follicular helper cells. This work extends previous knowledge regarding adaptive immune responses to MF59-adjuvanted vaccines, and, to our knowledge, for the first time an adjuvant used in human licensed products is shown to promote strong and persistent Ag-specific GC responses that might benefit the rational design of new vaccination strategies.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26170383     DOI: 10.4049/jimmunol.1402604

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: A case-based review.

Authors:  Margaret F Bassendine; Simon H Bridge
Journal:  Eur J Rheumatol       Date:  2019-12-16

Review 2.  Biologics to treat substance use disorders: Current status and new directions.

Authors:  Marco Pravetoni
Journal:  Hum Vaccin Immunother       Date:  2016-07-21       Impact factor: 3.452

3.  IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants.

Authors:  Anthony L Desbien; Natasha Dubois Cauwelaert; Steven J Reed; Hilton R Bailor; Hong Liang; Darrick Carter; Malcolm S Duthie; Christopher B Fox; Steven G Reed; Mark T Orr
Journal:  J Immunol       Date:  2016-10-28       Impact factor: 5.422

4.  Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice.

Authors:  Elinor Willis; Norbert Pardi; Kaela Parkhouse; Barbara L Mui; Ying K Tam; Drew Weissman; Scott E Hensley
Journal:  Sci Transl Med       Date:  2020-01-08       Impact factor: 17.956

Review 5.  Peripheral follicular helper T cells in acute viral diseases: a perspective on dengue.

Authors:  Luis A Sánchez-Vargas; Anuja Mathew
Journal:  Future Virol       Date:  2019-03-06       Impact factor: 1.831

6.  The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence.

Authors:  M Laudenbach; A M Tucker; S P Runyon; F I Carroll; M Pravetoni
Journal:  Vaccine       Date:  2015-09-26       Impact factor: 3.641

7.  Safety and efficiency of active immunization with detoxified antigen against scorpion venom: side effect evaluation.

Authors:  Nassrine Bachsais; Lila Boussag-Abib; Fatima Laraba-Djebari
Journal:  Inflamm Res       Date:  2017-05-17       Impact factor: 4.575

8.  Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques.

Authors:  Diego A Vargas-Inchaustegui; Andrew Demers; Julia M Shaw; Guobin Kang; David Ball; Iskra Tuero; Thomas Musich; Venkatramanan Mohanram; Thorsten Demberg; Tatiana S Karpova; Qingsheng Li; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2016-01-15       Impact factor: 5.422

9.  Exploiting Pre-Existing CD4+ T Cell Help from Bacille Calmette-Guérin Vaccination to Improve Antiviral Antibody Responses.

Authors:  Tony W Ng; Ariel S Wirchnianski; Anna Z Wec; J Maximilian Fels; Christopher T Johndrow; Kevin O Saunders; Hua-Xin Liao; John Chan; William R Jacobs; Kartik Chandran; Steven A Porcelli
Journal:  J Immunol       Date:  2020-06-08       Impact factor: 5.422

10.  An oil-in-water nanoemulsion enhances immunogenicity of H5N1 vaccine in mice.

Authors:  Weiping Cao; William G Davis; Jin Hyang Kim; Juan A De La Cruz; Andrew Taylor; Grant R Hendrickson; Amrita Kumar; Priya Ranjan; L Andrew Lyon; Jacqueline M Katz; Shivaprakash Gangappa; Suryaprakash Sambhara
Journal:  Nanomedicine       Date:  2016-04-23       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.